Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer. https://t.co/LVJnWA4Y2o
1,219 followers
19,291 followers
#JITC Research: Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer https://t.co/vUAFU0rh6e https://t.co/zSS4IsNK3E
440 followers
RT @sitcancer: #JITC Research: Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of…
19,291 followers
#JITC Research: Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer https://t.co/vUAFU0rh6e https://t.co/GQTz21NW1l